These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 16620391)

  • 1. Breast tumor copy number aberration phenotypes and genomic instability.
    Fridlyand J; Snijders AM; Ylstra B; Li H; Olshen A; Segraves R; Dairkee S; Tokuyasu T; Ljung BM; Jain AN; McLennan J; Ziegler J; Chin K; Devries S; Feiler H; Gray JW; Waldman F; Pinkel D; Albertson DG
    BMC Cancer; 2006 Apr; 6():96. PubMed ID: 16620391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
    Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
    Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
    Hawthorn L; Luce J; Stein L; Rothschild J
    BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution genomic and expression analyses of copy number alterations in breast tumors.
    Haverty PM; Fridlyand J; Li L; Getz G; Beroukhim R; Lohr S; Wu TD; Cavet G; Zhang Z; Chant J
    Genes Chromosomes Cancer; 2008 Jun; 47(6):530-42. PubMed ID: 18335499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines.
    Finn S; Smyth P; O'Regan E; Cahill S; Toner M; Timon C; Flavin R; O'Leary J; Sheils O
    Arch Pathol Lab Med; 2007 Jan; 131(1):65-73. PubMed ID: 17227125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
    Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
    Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F; Theillet C
    Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.
    Loo LW; Grove DI; Williams EM; Neal CL; Cousens LA; Schubert EL; Holcomb IN; Massa HF; Glogovac J; Li CI; Malone KE; Daling JR; Delrow JJ; Trask BJ; Hsu L; Porter PL
    Cancer Res; 2004 Dec; 64(23):8541-9. PubMed ID: 15574760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.
    Ghazani AA; Arneson N; Warren K; Pintilie M; Bayani J; Squire JA; Done SJ
    Neoplasia; 2007 Jun; 9(6):511-20. PubMed ID: 17603634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutations are associated with a particular pattern of genomic imbalances in breast carcinomas.
    Kleivi K; Diep CB; Pandis N; Heim S; Teixeira MR; Lothe RA
    J Pathol; 2005 Sep; 207(1):14-9. PubMed ID: 16007576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours.
    Kuijper A; Snijders AM; Berns EM; Kuenen-Boumeester V; van der Wall E; Albertson DG; van Diest PJ
    Cell Oncol; 2009; 31(1):31-9. PubMed ID: 19096148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.
    Beheshti B; Braude I; Marrano P; Thorner P; Zielenska M; Squire JA
    Neoplasia; 2003; 5(1):53-62. PubMed ID: 12659670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer.
    Chao HH; He X; Parker JS; Zhao W; Perou CM
    PLoS One; 2012; 7(12):e51719. PubMed ID: 23284754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico pathway analysis based on chromosomal instability in breast cancer patients.
    Kour A; Sambyal V; Guleria K; Singh NR; Uppal MS; Manjari M; Sudan M
    BMC Med Genomics; 2020 Nov; 13(1):168. PubMed ID: 33167967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability.
    Lung JC; Chu JS; Yu JC; Yue CT; Lo YL; Shen CY; Wu CW
    Genes Chromosomes Cancer; 2002 Jul; 34(3):276-84. PubMed ID: 12007188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.